Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control studyResearch in context
Lancet Regional Health - Americas (Online), 2023-11, Vol.27, p.100607 [Peer Reviewed Journal]ISSN: 2667-193X ;EISSN: 2667-193X
Full text available